The path to personalised medicine in COPD.

doi:10.1136/thoraxjnl-2014-205507

Back to search

Article

The path to personalised medicine in COPD.

Thorax - 1 Sept 2014

Agusti Alvar

Abstract excerpt

Our understanding of chronic obstructive pulmonary disease (COPD) has changed dramatically over the past two decades. We have moved from an airflow limitation-centric view to the realisation that COPD is a complex and heterogeneous disease, which leads inevitably to the need for personalising the...

Topics

Forced Expiratory Volume
Humans
Inflammation
Lung
Phenotype
Precision Medicine
Pulmonary Disease, Chronic Obstructive
Radiography
Severity of Illness Index

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.